CYTORA is a clinical stage stem cell company developing a new class of
medicines based on a novel and transformative patented
platform stem cell technology derived from unique
human Oral Mucosa Stem Cells (hOMSC)
human Oral Mucosa Stem Cells
A unique phenomenon occurs in the mouth.
Rapid Wound Healing compared to
No scars! - Full regeneration.
Regeneration is not affected by age!
This pattern of wound healing is negligibly affected by diabetes.
2 weeks later
Novel and Unique
Cytora’s patented and transformative platform stem cell technology is based on the discovery of a novel and unique stem cell population in the oral mucosa termed “human Oral Mucosa Stem Cells (hOMSC)”.
Under Clinical Development
Diabetic Wound Healing - Incurable Diabetic Foot Ulcer (IDFU) - Clinical Studies in Progress.
Central & Autonomic Nervous System - Multiple System Atrophy (MSA) - Clinical Studies in progress.
Highly qualified, deeply scientific team with years of research, patents and industry experience in the fields of biotechnology and stem cell therapy.
World renowned, expert scientific advisory board - Leading clinical experts in their respective fields.